Sanchez, I. M., Purwin, T. J., Chervoneva, I., Erkes, D. A., Nguyen, M. Q., Davies, M. A., . . . Aplin, A. E. (2019). In vivo ERK½ reporter predictively models response and resistance to combined BRAF and MEK inhibitors in melanoma. Mol Cancer Ther.
Chicago-tyylinen lähdeviittausSanchez, Ileine M., et al. "In Vivo ERK½ Reporter Predictively Models Response and Resistance to Combined BRAF and MEK Inhibitors in Melanoma." Mol Cancer Ther 2019.
MLA-viiteSanchez, Ileine M., et al. "In Vivo ERK½ Reporter Predictively Models Response and Resistance to Combined BRAF and MEK Inhibitors in Melanoma." Mol Cancer Ther 2019.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.